vs

Side-by-side financial comparison of First Bancorp, Inc (FNLC) and Outset Medical, Inc. (OM). Click either name above to swap in a different company.

Outset Medical, Inc. is the larger business by last-quarter revenue ($28.9M vs $25.8M, roughly 1.1× First Bancorp, Inc). First Bancorp, Inc runs the higher net margin — 39.4% vs -67.5%, a 106.9% gap on every dollar of revenue. On growth, First Bancorp, Inc posted the faster year-over-year revenue change (17.5% vs -2.0%). First Bancorp, Inc produced more free cash flow last quarter ($34.6M vs $-9.7M). Over the past eight quarters, First Bancorp, Inc's revenue compounded faster (18.1% CAGR vs 1.2%).

Patriot Bank, N.A. (PNBK) is the bank holding company for Stamford, Connecticut-based Patriot Bank NA, and is traded on NASDAQ as PNBK.

Outset Medical, Inc. is a medical technology company focused on developing and commercializing innovative dialysis solutions for patients living with kidney disease. Its flagship Tablo Hemodialysis System supports use in acute care facilities, outpatient clinics, and home settings, serving healthcare providers and patients across the U.S. and select international markets.

FNLC vs OM — Head-to-Head

Bigger by revenue
OM
OM
1.1× larger
OM
$28.9M
$25.8M
FNLC
Growing faster (revenue YoY)
FNLC
FNLC
+19.5% gap
FNLC
17.5%
-2.0%
OM
Higher net margin
FNLC
FNLC
106.9% more per $
FNLC
39.4%
-67.5%
OM
More free cash flow
FNLC
FNLC
$44.3M more FCF
FNLC
$34.6M
$-9.7M
OM
Faster 2-yr revenue CAGR
FNLC
FNLC
Annualised
FNLC
18.1%
1.2%
OM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FNLC
FNLC
OM
OM
Revenue
$25.8M
$28.9M
Net Profit
$10.2M
$-19.5M
Gross Margin
42.4%
Operating Margin
48.1%
-61.1%
Net Margin
39.4%
-67.5%
Revenue YoY
17.5%
-2.0%
Net Profit YoY
39.7%
24.0%
EPS (diluted)
$0.91
$0.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FNLC
FNLC
OM
OM
Q4 25
$25.8M
$28.9M
Q3 25
$24.5M
$29.4M
Q2 25
$22.5M
$31.4M
Q1 25
$21.8M
$29.8M
Q4 24
$22.0M
$29.5M
Q3 24
$20.5M
$28.7M
Q2 24
$19.2M
$27.4M
Q1 24
$18.5M
$28.2M
Net Profit
FNLC
FNLC
OM
OM
Q4 25
$10.2M
$-19.5M
Q3 25
$9.1M
$-17.8M
Q2 25
$8.1M
$-18.5M
Q1 25
$7.1M
$-25.8M
Q4 24
$7.3M
$-25.6M
Q3 24
$7.6M
$-27.9M
Q2 24
$6.2M
$-34.5M
Q1 24
$6.0M
$-39.9M
Gross Margin
FNLC
FNLC
OM
OM
Q4 25
42.4%
Q3 25
39.4%
Q2 25
37.8%
Q1 25
37.2%
Q4 24
36.5%
Q3 24
34.3%
Q2 24
35.7%
Q1 24
29.2%
Operating Margin
FNLC
FNLC
OM
OM
Q4 25
48.1%
-61.1%
Q3 25
45.2%
-53.7%
Q2 25
43.7%
-53.7%
Q1 25
39.3%
-55.1%
Q4 24
39.5%
-74.2%
Q3 24
44.6%
-83.2%
Q2 24
38.8%
-112.3%
Q1 24
39.3%
-131.0%
Net Margin
FNLC
FNLC
OM
OM
Q4 25
39.4%
-67.5%
Q3 25
37.0%
-60.6%
Q2 25
35.8%
-59.0%
Q1 25
32.5%
-86.7%
Q4 24
33.1%
-87.0%
Q3 24
36.9%
-97.5%
Q2 24
32.1%
-125.8%
Q1 24
32.5%
-141.8%
EPS (diluted)
FNLC
FNLC
OM
OM
Q4 25
$0.91
$0.33
Q3 25
$0.81
$-1.00
Q2 25
$0.72
$-1.04
Q1 25
$0.63
$-3.66
Q4 24
$0.66
$-7.21
Q3 24
$0.68
$-8.02
Q2 24
$0.55
$-9.96
Q1 24
$0.54
$-11.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FNLC
FNLC
OM
OM
Cash + ST InvestmentsLiquidity on hand
$168.9M
Total DebtLower is stronger
$95.5M
$96.2M
Stockholders' EquityBook value
$283.1M
$127.0M
Total Assets
$3.2B
$264.5M
Debt / EquityLower = less leverage
0.34×
0.76×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FNLC
FNLC
OM
OM
Q4 25
$168.9M
Q3 25
$178.6M
Q2 25
$184.1M
Q1 25
$189.0M
Q4 24
$158.7M
Q3 24
$175.6M
Q2 24
$194.8M
Q1 24
$226.9M
Total Debt
FNLC
FNLC
OM
OM
Q4 25
$95.5M
$96.2M
Q3 25
$95.5M
Q2 25
$95.0M
Q1 25
$70.0M
Q4 24
$95.0M
$197.4M
Q3 24
$95.0M
Q2 24
$70.0M
Q1 24
$70.0M
Stockholders' Equity
FNLC
FNLC
OM
OM
Q4 25
$283.1M
$127.0M
Q3 25
$274.6M
$142.4M
Q2 25
$265.5M
$154.8M
Q1 25
$259.7M
$169.9M
Q4 24
$252.5M
$26.8M
Q3 24
$256.8M
$47.8M
Q2 24
$244.7M
$68.6M
Q1 24
$242.6M
$93.2M
Total Assets
FNLC
FNLC
OM
OM
Q4 25
$3.2B
$264.5M
Q3 25
$3.2B
$277.3M
Q2 25
$3.2B
$288.8M
Q1 25
$3.2B
$301.2M
Q4 24
$3.2B
$275.8M
Q3 24
$3.1B
$292.9M
Q2 24
$3.1B
$314.5M
Q1 24
$3.0B
$346.2M
Debt / Equity
FNLC
FNLC
OM
OM
Q4 25
0.34×
0.76×
Q3 25
0.35×
Q2 25
0.36×
Q1 25
0.27×
Q4 24
0.38×
7.36×
Q3 24
0.37×
Q2 24
0.29×
Q1 24
0.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FNLC
FNLC
OM
OM
Operating Cash FlowLast quarter
$37.8M
$-9.5M
Free Cash FlowOCF − Capex
$34.6M
$-9.7M
FCF MarginFCF / Revenue
133.9%
-33.7%
Capex IntensityCapex / Revenue
12.5%
0.8%
Cash ConversionOCF / Net Profit
3.72×
TTM Free Cash FlowTrailing 4 quarters
$55.3M
$-47.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FNLC
FNLC
OM
OM
Q4 25
$37.8M
$-9.5M
Q3 25
$12.9M
$-6.3M
Q2 25
$7.4M
$-4.8M
Q1 25
$2.2M
$-25.7M
Q4 24
$26.0M
$-16.5M
Q3 24
$9.8M
$-20.6M
Q2 24
$6.4M
$-33.3M
Q1 24
$-1.5M
$-45.9M
Free Cash Flow
FNLC
FNLC
OM
OM
Q4 25
$34.6M
$-9.7M
Q3 25
$12.6M
$-6.5M
Q2 25
$7.2M
$-5.1M
Q1 25
$828.0K
$-25.8M
Q4 24
$24.6M
$-16.5M
Q3 24
$9.6M
$-21.0M
Q2 24
$6.3M
$-33.5M
Q1 24
$-1.8M
$-46.3M
FCF Margin
FNLC
FNLC
OM
OM
Q4 25
133.9%
-33.7%
Q3 25
51.4%
-22.0%
Q2 25
32.1%
-16.3%
Q1 25
3.8%
-86.7%
Q4 24
111.7%
-56.1%
Q3 24
47.0%
-73.1%
Q2 24
32.9%
-122.2%
Q1 24
-9.8%
-164.3%
Capex Intensity
FNLC
FNLC
OM
OM
Q4 25
12.5%
0.8%
Q3 25
1.2%
0.5%
Q2 25
0.6%
0.9%
Q1 25
6.2%
0.4%
Q4 24
6.7%
0.1%
Q3 24
0.5%
1.4%
Q2 24
0.3%
0.4%
Q1 24
1.8%
1.3%
Cash Conversion
FNLC
FNLC
OM
OM
Q4 25
3.72×
Q3 25
1.42×
Q2 25
0.91×
Q1 25
0.31×
Q4 24
3.58×
Q3 24
1.29×
Q2 24
1.03×
Q1 24
-0.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FNLC
FNLC

Segment breakdown not available.

OM
OM

Consumables Product$13.5M47%
Service And Other Revenue$9.0M31%
Consoles Product$6.4M22%

Related Comparisons